During this webcast, Dr. Patrick Fransen will present clinical data from a prospective, randomized, controlled study of 20 patients who were treated with a synthetic, bioabsorbable adhesion barrier with 1-, 3- and 6-months post op follow up. Dr. Fransen will also share clinical images and videos.
Participants can submit questions during the broadcast that will be answered by Dr. Fransen after the presentation.
This program features the DuraSeal Xact™ Adhesion Barrier and Sealant System. It is intended for audiences outside the United States where the DuraSeal Xact™ Adhesion Barrier and Sealant System has CE mark approval, and is intended for use during spine procedures as an adjunct to standard methods of dural repair, such as sutures, to provide watertight closure, and as an adhesion barrier for the inhibition of post-surgical peridural fibrosis.
This program is sponsored by Covidien
Patrick Fransen, MD